journal
Journals Clinical and Vaccine Immunolog...

Clinical and Vaccine Immunology : CVI

https://read.qxmd.com/read/28637803/protein-malnutrition-alters-tryptophan-and-angiotensin-converting-enzyme-2-homeostasis-and-adaptive-immune-responses-in-human-rotavirus-infected-gnotobiotic-pigs-with-human-infant-fecal-microbiota-transplant
#41
JOURNAL ARTICLE
David D Fischer, Sukumar Kandasamy, Francine C Paim, Stephanie N Langel, Moyasar A Alhamo, Lulu Shao, Juliet Chepngeno, Ayako Miyazaki, Huang-Chi Huang, Anand Kumar, Gireesh Rajashekara, Linda J Saif, Anastasia N Vlasova
Malnutrition leads to increased morbidity and is evident in almost half of all deaths in children under the age of 5 years. Mortality due to rotavirus diarrhea is common in developing countries where malnutrition is prevalent; however, the relationship between malnutrition and rotavirus infection remains unclear. In this study, gnotobiotic pigs transplanted with the fecal microbiota of a healthy 2-month-old infant were fed protein-sufficient or -deficient diets and infected with virulent human rotavirus (HRV)...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28592628/chemiluminescence-immunoassay-for-the-detection-of-antibodies-against-the-2c-and-3abc-nonstructural-proteins-induced-by-infecting-pigs-with-foot-and-mouth-disease-virus
#42
JOURNAL ARTICLE
Zezhong Liu, Junjun Shao, Furong Zhao, Guangqing Zhou, Shandian Gao, Wei Liu, Jianliang Lv, Xiumei Li, Yangfan Li, Huiyun Chang, Yongguang Zhang
The potential diagnostic value of chemiluminescence immunoassays (CLIAs) has been accepted in recent years, although their use for foot-and-mouth disease (FMD) diagnostics has not been reported. Full-length 3ABC and 2C proteins were expressed in bacteria and purified by affinity chromatography to develop a rapid and accurate approach to distinguish pigs infected with foot-and-mouth disease virus (FMDV) from vaccinated pigs. The recombinant proteins were then used as antigens to develop two CLIAs for the detection of antibodies against nonstructural viral proteins...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28592627/cytokines-are-markers-of-the-clostridium-difficile-induced-inflammatory-response-and-predict-disease-severity
#43
JOURNAL ARTICLE
Hua Yu, Kevin Chen, Ying Sun, Mihaela Carter, Kevin W Garey, Tor C Savidge, Sridevi Devaraj, Mary Elizabeth Tessier, Erik C von Rosenvinge, Ciaran P Kelly, Marcela F Pasetti, Hanping Feng
The host immune response affects pathogen virulence in Clostridium difficile infection (CDI). Thus, cytokine responses to CDI likely are associated with disease initiation and progression. Understanding the molecular drivers of inflammation and biochemical markers of disease severity is important for developing novel therapies and predicting disease prognosis. In this study, we investigated cytokine production in patients with CDI and evaluated the potential of cytokines to serve as biomarkers for CDI and predictors of disease severity...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28592626/longitudinal-ip-10-serum-levels-are-associated-with-the-course-of-disease-activity-and-remission-in-patients-with-rheumatoid-arthritis
#44
JOURNAL ARTICLE
Anouk van Hooij, Debbie M Boeters, Elisa M Tjon Kon Fat, Susan J F van den Eeden, Paul L A M Corstjens, Annette H M van der Helm-van Mil, Annemieke Geluk
Although rheumatoid arthritis (RA) is a chronic, persistent autoimmune disease, 10 to 15% of RA patients achieve sustained disease-modifying antirheumatic drug (DMARD)-free remission over time. The biological mechanisms underlying the resolution of persistent inflammation in RA are still unidentified, and there is a lack of prognostic markers. It is well established that increased serum levels of gamma interferon-induced protein 10 (IP-10) are associated with (acute) increased inflammatory responses (e.g., in leprosy)...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28566336/maternal-humoral-immune-correlates-of-peripartum-transmission-of-clade-c-hiv-1-in-the-setting-of-peripartum-antiretrovirals
#45
JOURNAL ARTICLE
Charmaine P Mutucumarana, Joshua Eudailey, Erin P McGuire, Nathan Vandergrift, Gerald Tegha, Charles Chasela, Sascha Ellington, Charles van der Horst, Athena P Kourtis, Sallie R Permar, Genevieve G Fouda
Despite the widespread use of antiretrovirals (ARV), more than 150,000 pediatric HIV-1 infections continue to occur annually. Supplemental strategies are necessary to eliminate pediatric HIV infections. We previously reported that maternal HIV envelope-specific anti-V3 IgG and CD4 binding site-directed antibodies, as well as tier 1 virus neutralization, predicted a reduced risk of mother-to-child transmission (MTCT) of HIV-1 in the pre-ARV era U.S.-based Women and Infants Transmission Study (WITS) cohort. As the majority of ongoing pediatric HIV infections occur in sub-Saharan Africa, we sought to determine if the same maternal humoral immune correlates predicted MTCT in a subset of the Malawian Breastfeeding, Antiretrovirals, and Nutrition (BAN) cohort of HIV-infected mothers ( n = 88, with 45 transmitting and 43 nontransmitting)...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28566335/breadth-and-duration-of-meningococcal-serum-bactericidal-activity-in-health-care-workers-and-microbiologists-immunized-with-the-menb-fhbp-vaccine
#46
JOURNAL ARTICLE
Eduardo Lujan, Elizabeth Partridge, Serena Giuntini, Sanjay Ram, Dan M Granoff
MenB-FHbp is a meningococcal serogroup B vaccine with two factor H binding protein (FHbp) antigens from subfamilies A and B. For licensure, efficacy was inferred from serum bactericidal antibody (SBA) responses to four reference strains. Only limited information is available on the breadth or duration of protective SBA responses to genetically diverse disease-causing strains. Seventeen health care or laboratory workers were immunized with two ( n = 2) or three ( n = 15) doses of MenB-FHbp at 0, 2, and 6 months...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28747311/an-n-terminal-pfs230-domain-produced-in-baculovirus-as-a-biological-active-transmission-blocking-vaccine-candidate
#47
JOURNAL ARTICLE
Shwu-Maan Lee, Chia-Kuei Wu, Jordan L Plieskatt, Kazutoyo Miura, John M Hickey, C Richter King
Transmission-blocking vaccines have the potential to accelerate malaria parasite elimination by inducing antibodies that block parasite transmission from humans to mosquitoes. Pfs230, a gametocyte surface protein involved in gamete function, has long been a promising candidate. Due to the large size (3,135 amino acids), complex domains, and repeating six-cysteine (6-Cys) motifs with a multitude of disulfide bonds, the feasibility of expression of a full-length protein has been difficult. A priority focus, therefore, has been on the generation of single domains, including N-terminal fragments...
July 26, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28724524/assignment-of-weight-based-antibody-units-for-four-additional-serotypes-to-a-human-anti-pneumococcal-standard-reference-serum-007sp
#48
JOURNAL ARTICLE
D Goldblatt, A McKeen, P Burbidge, S McElhiney, L McLaughlin, A Johnson, M Rauh, P C Giardina
The pneumococcal ELISA reference standard serum, Lot 89SF, has been in use since 1990 and was replaced with a new reference standard serum, 007sp in 2013. This serum was generated under an FDA-approved clinical protocol, where 278 adult volunteers were immunized with the 23-valent unconjugated polysaccharide vaccine, Pneumovax II®, and a unit of blood was obtained twice within 120 days following immunization. Pooled serum was prepared from the plasma, filled at 6ml per vial and lyophilised. Five independent laboratories participated in bridging the serotype specific IgG assignments for 89SF to 007sp to establish equivalent reference values for 13 pneumococcal capsular serotypes (1,3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) using the WHO reference ELISA...
July 19, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28515136/loss-of-humoral-and-cellular-immunity-to-invasive-nontyphoidal-salmonella-during-current-or-convalescent-plasmodium-falciparum-infection-in-malawian-children
#49
JOURNAL ARTICLE
Tonney S Nyirenda, James T Nyirenda, Dumizulu L Tembo, Janet Storm, Queen Dube, Chisomo L Msefula, Kondwani C Jambo, Henry C Mwandumba, Robert S Heyderman, Melita A Gordon, Wilson L Mandala
Invasive nontyphoidal Salmonella (iNTS) infections are commonly associated with Plasmodium falciparum infections, but the immunologic basis for this linkage is poorly understood. We hypothesized that P. falciparum infection compromises the humoral and cellular immunity of the host to NTS, which increases the susceptibility of the host to iNTS infection. We prospectively recruited children aged between 6 and 60 months at a Community Health Centre in Blantyre, Malawi, and allocated them to the following groups; febrile with uncomplicated malaria, febrile malaria negative, and nonfebrile malaria negative...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28515135/not-all-antigens-are-created-equally-progress-challenges-and-lessons-associated-with-developing-a-vaccine-for-leishmaniasis
#50
REVIEW
Malcolm S Duthie, Steven G Reed
From experimental models and the analyses of patients, it is well documented that antigen-specific T cells are critical for protection against Leishmania infection. Effective vaccines require both targeting to the pathogen and an immune stimulant to induce maturation of appropriate immune responses. While a great number of antigens have been examined as vaccine candidates against various Leishmania species, few have advanced to human or canine clinical trials. With emphasis on antigen expression, in this minireview we discuss some of the vaccine platforms that are currently being explored for the development of Leishmania vaccines...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28515134/identification-of-novel-seroreactive-antigens-in-johne-s-disease-cattle-by-using-the-mycobacterium-tuberculosis-protein-array
#51
JOURNAL ARTICLE
John P Bannantine, Joseph J Campo, Lingling Li, Arlo Randall, Jozelyn Pablo, Craig A Praul, Juan Antonio Raygoza Garay, Judith R Stabel, Vivek Kapur
Johne's disease, a chronic gastrointestinal inflammatory disease caused by Mycobacterium avium subspecies paratuberculosis , is endemic in dairy cattle and other ruminants worldwide and remains a challenge to diagnose using traditional serological methods. Given the close phylogenetic relationship between M. avium subsp. paratuberculosis and the human pathogen Mycobacterium tuberculosis , here, we applied a whole-proteome M. tuberculosis protein array to identify seroreactive and diagnostic M. avium subsp. paratuberculosis antigens...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28515133/development-of-a-novel-virus-like-particle-vaccine-platform-that-mimics-the-immature-form-of-alphavirus
#52
JOURNAL ARTICLE
Akane Urakami, Atsuko Sakurai, Momoko Ishikawa, Moh Lan Yap, Yevel Flores-Garcia, Yasunari Haseda, Taiki Aoshi, Fidel P Zavala, Michael G Rossmann, Sachiko Kuno, Ryuji Ueno, Wataru Akahata
Virus-like particles (VLPs) are noninfectious multiprotein structures that are engineered to self-assemble from viral structural proteins. Here, we developed a novel VLP-based vaccine platform utilizing VLPs from the chikungunya virus. We identified two regions within the envelope protein, a structural component of chikungunya, where foreign antigens can be inserted without compromising VLP structure. Our VLP displays 480 copious copies of an inserted antigen on the VLP surface in a highly symmetric manner and is thus capable of inducing strong immune responses against any inserted antigen...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28490424/waning-immunity-and-microbial-vaccines-workshop-of-the-national-institute-of-allergy-and-infectious-diseases
#53
Xin-Xing Gu, Stanley A Plotkin, Kathryn M Edwards, Alessandro Sette, Kingston H G Mills, Ofer Levy, Andrea J Sant, Annie Mo, William Alexander, Kristina T Lu, Christopher E Taylor
Since the middle of the 20th century, vaccines have made a significant public health impact by controlling infectious diseases globally. Although long-term protection has been achieved with some vaccines, immunity wanes over time with others, resulting in outbreaks or epidemics of infectious diseases. Long-term protection against infectious agents that have a complex life cycle and antigenic variation remains a key challenge. Novel strategies to characterize the short- and long-term immune responses to vaccines and to induce immune responses that mimic natural infection have recently emerged...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28468981/human-neutrophil-lipocalin-in-activated-whole-blood-is-a-specific-and-rapid-diagnostic-biomarker-of-bacterial-infections-in-the-respiratory-tract
#54
COMPARATIVE STUDY
Per Venge, Ann-Katrin Eriksson, Lena Douhan-Håkansson, Karlis Pauksen
The distinction between bacterial and viral causes of infections of the respiratory tract is a major but important clinical challenge. We investigated the diagnostic performance of human neutrophil lipocalin (HNL) in respiratory tract infections compared to those of C-reactive protein (CRP) and procalcitonin (PCT). Patients were recruited from the emergency department and from a primary care unit ( n = 162). The clinical diagnosis with regard to bacterial or viral cause of infection was complemented with objective microbiological/serological testing...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28468980/identification-of-protective-b-cell-epitopes-within-the-novel-malaria-vaccine-candidate-plasmodium-falciparum-schizont-egress-antigen-1
#55
JOURNAL ARTICLE
Christina E Nixon, Sangshin Park, Sunthorn Pond-Tor, Dipak Raj, Lynn E Lambert, Sachy Orr-Gonzalez, Emma K Barnafo, Kelly M Rausch, Jennifer F Friedman, Michal Fried, Patrick E Duffy, Jonathan D Kurtis
Naturally acquired antibodies to Plasmodium falciparum schizont egress antigen 1 (PfSEA-1A) are associated with protection against severe malaria in children. Vaccination of mice with SEA-1A from Plasmodium berghei (PbSEA-1A) decreases parasitemia and prolongs survival following P. berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear B-cell epitopes using peptide microarrays probed with antisera from nonhuman primates vaccinated with recombinant PfSEA-1A (rPfSEA-1A). We evaluated the relationship between epitope-specific antibody levels and protection from parasitemia in a longitudinal treatment-reinfection cohort in western Kenya...
July 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28659326/a-cation-binding-surface-protein-as-a-vaccine-antigen-to-prevent-moraxella-catarrhalis-otitis-media-and-infections-in-chronic-obstructive-pulmonary-disease
#56
JOURNAL ARTICLE
Timothy F Murphy, Aimee L Brauer, Antoinette Johnson, Gregory E Wilding, Mary Koszelak-Rosenblum, Michael G Malkowski
Moraxella catarrhalis is an exclusively human respiratory tract pathogen that is a common cause of otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. A vaccine to prevent these infections would have a major impact in reducing the substantial global morbidity and mortality in these populations. Through a genome mining approach, we identified AfeA, an ∼32 kDa substrate binding protein of an ABC transport system as an excellent candidate vaccine antigen...
June 28, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28446441/long-term-persistence-of-cell-mediated-and-humoral-responses-to-a-h1n1-pdm09-influenza-virus-vaccines-and-the-role-of-the-as03-adjuvant-system-in-adults-during-two-randomized-controlled-trials
#57
RANDOMIZED CONTROLLED TRIAL
Robbert G van der Most, Frédéric Clément, Julie Willekens, Walthère Dewé, Karl Walravens, David W Vaughn, Geert Leroux-Roels
We investigated the role of AS03A (here AS03), an α-tocopherol oil-in-water emulsion-based adjuvant system, on the long-term persistence of humoral and cell-mediated immune responses to A(H1N1)pdm09 influenza vaccines. In two studies, a total of 261 healthy adults (≤60 years old) were randomized to receive two doses of AS03-adjuvanted vaccine containing 3.75 μg of hemagglutinin (HA) or nonadjuvanted vaccine containing 15 μg of hemagglutinin (in study A) or 3.75 μg of hemagglutinin (in study B) 21 days apart...
June 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28424198/pneumococcal-capsular-polysaccharide-immunity-in-the-elderly
#58
REVIEW
Hugh Adler, Daniela M Ferreira, Stephen B Gordon, Jamie Rylance
Immunity to pneumococcal infections is impaired in older people, and current vaccines are poorly protective against pneumococcal disease in this population. Naturally acquired immunity to pneumococcal capsular polysaccharides develops during childhood and is robust in young adults but deteriorates with advanced age. In particular, antibody levels and function are reduced in older people. Pneumococcal vaccines are recommended for people >65 years old. However, the benefits of polysaccharide and protein-conjugated vaccines in this population are small, because of both serotype replacement and incomplete protection against vaccine serotype pneumococcal disease...
June 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28404574/parasitic-infections-in-pregnancy-decrease-placental-transfer-of-antipneumococcus-antibodies
#59
JOURNAL ARTICLE
Noah D McKittrick, David M Vu, Indu Malhotra, Charles H King, Francis Mutuku, A Desiree LaBeaud
Many factors can influence maternal placental antibody transfer to the fetus, which confers important immune protection to the newborn infant. However, little is known about the effect of maternal parasitic infection on placental antibody transfer. To investigate this, we selected from a parent study of 576 pregnant Kenyan women four groups of women with term deliveries (≥37 weeks), including uninfected women ( n = 30) and women with solo infections with malaria ( n = 30), hookworm ( n = 30), or schistosomiasis ( n = 10)...
June 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28404573/cytomegalovirus-virions-shed-in-urine-have-a-reversible-block-to-epithelial-cell-entry-and-are-highly-resistant-to-antibody-neutralization
#60
JOURNAL ARTICLE
Xiaohong Cui, Stuart P Adler, Mark R Schleiss, Ravit Arav-Boger, Gail J Demmler Harrison, Michael A McVoy
Cytomegalovirus (CMV) causes sensorineural hearing loss and developmental disabilities in newborns when infections are acquired in utero Pregnant women may acquire CMV from oral exposure to CMV in urine or saliva from young children. Neutralizing antibodies in maternal saliva have the potential to prevent maternal infection and, in turn, fetal infection. As CMV uses different viral glycoprotein complexes to enter different cell types, the first cells to be infected in the oral cavity could determine the type of antibodies needed to disrupt oral transmission...
June 2017: Clinical and Vaccine Immunology: CVI
journal
journal
41110
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.